From the Healthcare Businesswomen’s Association (HBA) Panel Discussion – How to Survive in the Age of Disruption: The Future of Healthcare Marketing on December 5, 2017.
On an early crisp December morning, a group of forward thinking pharmaceutical executives gathered at J&J Diabetes Care for an executive breakfast panel discussion on the disruption of the healthcare industry and what the future holds. Moderated by Maria Finlay, Associate Director of Oncology Marketing, Teva Oncology, a lively panel discussion among some of the authors of RESULTS: The Future of Pharmaceutical & Healthcare Marketing as well as Director of Digital Media for Lifescan, a J&J company, marketer Fran Howell took place. Our own R.J. Lewis, author of RESULTS, participated on the panel as well. These video clips capture much of the dialogue as well as audience Q&A.
Fran Howell – Director of Digital Media, Johnson & Johnson Diabetes Institute
RJ Lewis – Founder & CEO of eHealthcare Solutions and co-author of the book “Results: The Future of Healthcare and Pharmaceutical Marketing”
Scott Weintraub – Co-Founder & President, Relative Healthcare Group and co-author of the book “Results: The Future of Healthcare and Pharmaceutical Marketing”
Elena Stavrakas – Director, Healthcare Life Sciences, Navigant.
Moderated by Maria Finlay, Associate Director, Oncology Marketing, Teva Pharmaceuticals.
Sponsored by Johnson & Johnson Diabetes Institute.
HBA Panel Discussion – Opening Remarks
Introduced by Amy Turnquist, HBA Philadelphia Chapter 2018 Incoming President, Amparo Gonzalez, Senior Director Global Professional Education and the Johnson & Johnson Diabetes Institute, shares some opening remarks.